Director Makes Bold Move With Major Stock Purchase in Zenas BioPharma!

TipRanksFeb 11 21:02 ET

Insider Purchase: Director at $ZBIO Buys 10,000 Shares

Quiver QuantitativeFeb 11 16:34 ET

Zenas BioPharma Reports Strong 2024 Momentum, Eyes 2025 Milestones In Obexelimab Trials for Lupus, Multiple Sclerosis, And IgG4-RD

BenzingaFeb 5 07:24 ET

Zenas BioPharma Announces Objectives for 2025

TipRanksFeb 5 07:16 ET

Express News | Zenas Biopharma- Cash Equivalents, Short-Term Investments as of Dec 31 to Fund Operating Expenses & Capex Requirements Into Q4 2026

ReutersFeb 5 07:09 ET

Express News | Zenas Biopharma : Topline Results From Phase 2 Trial in Relapsing Multiple Sclerosis (Moonstone) Expected in Q3 2025

ReutersFeb 5 07:08 ET